PALBOCICLIB IN THE DAILY CLINICAL USE: REAL EXPERIENCE IN METASTATIC BREAST CANCER IN OUR INSTITUTION

被引:1
作者
Mainella, A. [1 ]
Marmissolle, F. [1 ]
Vigo, S. [1 ]
Price, P. [1 ]
Sansano, M. [1 ]
Lujan, M. L. [1 ]
Dominguez, Mp [1 ]
Caamano, G. Zapata [1 ]
Menna, E. [1 ]
Giacomi, N. [1 ]
机构
[1] COI La Plata, Ctr Oncol Integral, La Plata, Argentina
关键词
D O I
10.1136/ijgc-2020-IGCS.207
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
IGCS20_124
引用
收藏
页码:A98 / A99
页数:2
相关论文
共 50 条
  • [41] Capecitabine Alone or in Combination in Metastatic Breast Cancer - a Single-Institution Experience
    Arcana, C.
    Ingemi, M. C.
    Smiroldo, V.
    Berenato, F.
    Spadaro, P.
    EUROPEAN JOURNAL OF CANCER, 2011, 47 : S347 - S347
  • [42] Breast cancer with synchronous and metachronous metastatic spreading. A single institution experience
    Vandone, A. M.
    Garrone, O.
    Vanella, P.
    Brizio, R.
    Miraglio, E.
    Comino, A.
    Merlano, M. C.
    ANNALS OF ONCOLOGY, 2016, 27
  • [43] Real world outcomes with alpelisib in metastatic hormone receptor-positive breast cancer patients: A single institution experience
    Alaklabi, Sabah
    Roy, Arya Mariam
    Attwood, Kristopher
    George, Anthony
    O'Connor, Tracey
    Early, Amy
    Levine, Ellis G.
    Gandhi, Shipra
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [44] Palbociclib use with grade 3 neutropenia in hormone receptor-positive metastatic breast cancer
    Ham, Ahrong
    Kim, Min Hwan
    Kim, Gun Min
    Kim, Jee Hung
    Kim, Jee Ye
    Park, Hyung Seok
    Park, Seho
    Cho, Young Up
    Park, Byeong Woo
    Kim, Seung Il
    Sohn, Joohyuk
    BREAST CANCER RESEARCH AND TREATMENT, 2020, 183 (01) : 107 - 116
  • [45] Real-World Data of Palbociclib in Combination With Endocrine Therapy for the Treatment of Metastatic Breast Cancer in Men
    Kraus, Albert L.
    Yu-Kite, Michelle
    Mardekian, Jack
    Cotter, Matthew J.
    Kim, Sindy
    Decembrino, Jaclyn
    Snow, Tamara
    Carson, Kenneth R.
    Rockland, Jillian Motyl
    Gossai, Anala
    Wilner, Keith
    Wang, Diane D.
    Bartlett, Cynthia Huang
    Oharu, Norihiko
    Schnell, Patrick
    VanArsdale, Todd
    Lu, Dongrui R.
    Tursi, Jennifer M.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2022, 111 (01) : 302 - 309
  • [46] A CASE OF PSEUDOCIRRHOSIS IN METASTATIC BREAST CANCER AFTER TREATMENT WITH PALBOCICLIB
    Evans, Aron
    Tran, Huy
    Ansari, Mohammad S.
    HEPATOLOGY, 2022, 76 : S1442 - S1443
  • [47] Clinical Features and Prognosis of Primary Tracheal Cancer at Our Institution's Experience
    Mishina, Y.
    Arai, H.
    Nakamura, S.
    Masuda, H.
    Shiino, K.
    Okudela, K.
    Iwasawa, T.
    Tajiri, M.
    Masuda, M.
    JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) : S862 - S863
  • [48] Palbociclib use with grade 3 neutropenia in hormone receptor-positive metastatic breast cancer
    Ahrong Ham
    Min Hwan Kim
    Gun Min Kim
    Jee Hung Kim
    Jee Ye Kim
    Hyung Seok Park
    Seho Park
    Young Up Cho
    Byeong Woo Park
    Seung Il Kim
    Joohyuk Sohn
    Breast Cancer Research and Treatment, 2020, 183 : 107 - 116
  • [49] Real-world benefit of combination palbociclib and endocrine therapy for metastatic breast cancer and correlation with neutropenia
    Sun, James
    Zhong, Xiaojun
    Ma, Junjie
    Sun, Weihong
    Han, Hyo S.
    Soliman, Hatem H.
    Loftus, Loretta S.
    Costa, Ricardo L. B.
    Armaghani, Avan J.
    Soyano-Muller, Aixa E.
    Czerniecki, Brian J.
    Lee, M. Catherine
    Kiluk, John, V
    Khakpour, Nazanin
    Hoover, Susan J.
    Laronga, Christine
    Khong, Hung T.
    CANCER MEDICINE, 2021, 10 (21): : 7665 - 7672
  • [50] Correction to: Real-World Tumor Response of Palbociclib Plus Letrozole Versus Letrozole for Metastatic Breast Cancer in US Clinical Practice
    Adam Brufsky
    Xianchen Liu
    Benjamin Li
    Lynn McRoy
    Rachel M. Layman
    Targeted Oncology, 2021, 16 : 865 - 865